IMUNNOPHENOTYPIC CHANGES IN JMML PATIENTS TREATED WITH 5-AZACITIDINE AND CORRELATION WITH CLINICAL RESPONSE
Sign Up to like & getrecommendations! Published in 2021 at "Hematology, Transfusion and Cell Therapy"
DOI: 10.1016/j.htct.2021.10.488
Abstract: Background 5-azacitidine has been considered to be safe and efficient medication for use as a bridge to hemotopoietic stem cell transplantation in JMML patients. Patients under clinical treatment can be stratified as complete or partial… read more here.
Keywords: patients treated; response; treatment; jmml patients ... See more keywords